FHIR Implementation Guide for HCX
0.7.1 - CI Build

FHIR Implementation Guide for HCX - Local Development build (v0.7.1). See the Directory of published versions

ValueSet: HCX informational-messages-codes

Summary

Defining URL:https://ig.hcxprotocol.io/v0.7.1/ValueSet-informational-messages-codes.html
Version:0.7.1
Name:InformationalMessagesCodes
Status:Active as of 2022-06-01
Definition:

This is the value set that includes the informational messages codes

Publisher:HCX Open Community
Source Resource:XML / JSON / Turtle

References

Logical Definition (CLD)

No formal definition provided for this ValueSet

 

Expansion

This value set contains 136 concepts

CodeSystemDisplay
  MG045Ahttp://hcxprotocol.io/codes/informational-messages-codesDialysis payable separately as an add on package
  MG072Ahttp://hcxprotocol.io/codes/informational-messages-codesPackage cost of one session
  MG075Ahttp://hcxprotocol.io/codes/informational-messages-codesRs. 5000 is the upper limit. Can be booked at a lower rate also. In fact the SHA should examine this package and confirm wheter the package has been booked at the usual market rate. Can be booked for a pt. already admitted under any medical package.
  MO014Fhttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant and adjuvant rectal cancer
  MO062A1http://hcxprotocol.io/codes/informational-messages-codesACUTE LYMPHOBLASTIC LEUKEMIA
  MR001Ahttp://hcxprotocol.io/codes/informational-messages-codesThe Procedure will cover ALL, Hodgkin's Lymphoma, Wilm's Tumour, NHL, Retinoblastoma & certain Bone Tumours`
  SB030Ahttp://hcxprotocol.io/codes/informational-messages-codesCan be used for ORIF, wherever indicated. Can not be used as an Add - on package
  SB032Ahttp://hcxprotocol.io/codes/informational-messages-codesSurgical Management for Type III & IV Rockwood to be decided by the surgeon on case to case basis Type V & VI to be taken up for Surgery straight away In case Type I or II is booked a Pop Up to be shown "For Rockwood Type I & II - AC Joint injury, experts recommend Medical Management, are you sure you want to do Surgical Correction in this case ?" For Hospitals booking Surgical Correction in Type I & Type II cases, Medical Audit will be conducted.
  SB032Chttp://hcxprotocol.io/codes/informational-messages-codesSurgical Management for Type III & IV Rockwood to be decided by the surgeon on case to case basis Type V & VI to be taken up for Surgery straight away
  SB070Ahttp://hcxprotocol.io/codes/informational-messages-codesLA for - K Wire & Screw GA for - Nail & Plate
  SC076Ahttp://hcxprotocol.io/codes/informational-messages-codesIf the Hospital choses Pediatric Port in a pt. aged more than 14 years. Then it should be audited
  SE012Ahttp://hcxprotocol.io/codes/informational-messages-codesThe package is inclusive of Eye Bank processing fee
  SE012Bhttp://hcxprotocol.io/codes/informational-messages-codesThis is a special follow up package, as in Corneal graft surgery, a follow up at 1 week is required. At this time, the surgeon has to examine and then prescribe medicine for next one month. The medicine for 1 month has to be given at the time of booking this package. A signed reciept from the pt. is an essential document
  SE018Ahttp://hcxprotocol.io/codes/informational-messages-codesTo be done only after a prior scleral buckling surgery history
  SE022Ahttp://hcxprotocol.io/codes/informational-messages-codesCan be booked only after 1 year of cataract surgery
  SE025Ahttp://hcxprotocol.io/codes/informational-messages-codesCan be booked as a complication of cataract surgery atleast 15 days after discharge
  SE029Ahttp://hcxprotocol.io/codes/informational-messages-codesThe procedure is done only once per eye and not repeated
  SE029Bhttp://hcxprotocol.io/codes/informational-messages-codes1. Claim to be raised after all 3 sittings have been done per eye. 2. The interval between subsequent sittings is atleast 1 week.
  SE033Ahttp://hcxprotocol.io/codes/informational-messages-codesPre-auth to be raised only in cases which have a prior history of Vitreoretinal surgery done atleast 3 months ago
  SG097Ahttp://hcxprotocol.io/codes/informational-messages-codesCan be booked only after 15 days of Ileostomy and then every 2 months thereafter till the closure of stoma. The Hospital has to upload a signed statement from pt. that s/he has received the cosnumables: Ileostomy - bags, adhesive, clips etc for 2 months
  SG097Bhttp://hcxprotocol.io/codes/informational-messages-codesCan be booked only after 15 days of Colostomy and then every 2 months thereafter till the closure of stoma. The Hospital has to upload a signed statement from pt. that s/he has received the cosnumables: colostomy - bags, adhesive, clips etc for 2 months
  SU052Ahttp://hcxprotocol.io/codes/informational-messages-codesPayment to be made after completion of one month.
  SU060Ahttp://hcxprotocol.io/codes/informational-messages-codesClaim to be raised after 6th Cycle
  SU060Bhttp://hcxprotocol.io/codes/informational-messages-codesClaim for Rs. 15,000 can be raised after 6th Cycle. Remainaing Rs. 15,000 can be claimed after 12th Cycle
  SU071Chttp://hcxprotocol.io/codes/informational-messages-codesNo payment to be done to the Hospital for this stage The package can be booked only if the first stage package has been booked prior to this
  SU071Dhttp://hcxprotocol.io/codes/informational-messages-codesThe package can be booked only if the first stage and / or intermediate stage package has been booked prior to this
  SV032Ahttp://hcxprotocol.io/codes/informational-messages-codesAssociated with CABG Need to submit Barcode/ ID number of IABP. Intra-operative use of IABP as a part of operative strategy, not included Incidence - 5% to 7% Scrutiny of Hospitals where incidence is more than twice of prescribed limit
  MO001Ahttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant therapy in breast cancer Metastatic breast cancer (should not have received the same regimen or AC earlier)
  MO001Bhttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant therapy after 4 cycles of AC or EC
  MO001Chttp://hcxprotocol.io/codes/informational-messages-codesMetstatic breast cancer
  MO001Dhttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant therapy in breast cancer with cardiac dysfunction or not suitable for anthracycline based therapy Metstatic breast cancer (should not have received the same regimen earlier)
  MO001Ehttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant therapy in breast cancer with cardiac dysfunction or not suitable for anthracycline based therapy and high nodal burden Metastatic breast cancer (should not have received the same regimen earlier)
  MO001Fhttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant therapy in breast cancer with Her-2 neu positive patients
  MO001Ghttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant or neoadjuvant therapy in ER / PR psotive breast cancer ER / PR positive metastatic breast cancer (if not receive earlier)
  MO001Hhttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant or neoadjuvant therapy in ER / PR psotive breast cancer ER / PR positive metastatic breast cancer
  MO001Ihttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant or neoadjuvant therapy breast cancer metastatic breast cancer (if not received earlier)
  MO001Lhttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant therapy in breast cancer Metstatic breast cancer (should not have received the same regimen or EC earlier)
  MO001Mhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic breast cancer ER / PR positive
  MO001Nhttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant or neoadjuvant therapy breast cancer metastatic breast cancer
  MO001Ohttp://hcxprotocol.io/codes/informational-messages-codesMetastatic breast cancer ER / PR positive
  MO002Ahttp://hcxprotocol.io/codes/informational-messages-codesMetastatic bone malignancy and multiple myeloma
  MO003Ahttp://hcxprotocol.io/codes/informational-messages-codesMetastatic ovarian adenocarcinoma second line
  MO003Bhttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, adjuvant and metastatic ovarian adenocarcinoma
  MO004Ahttp://hcxprotocol.io/codes/informational-messages-codesTesticular Seminoma, Adjuvant
  MO004Bhttp://hcxprotocol.io/codes/informational-messages-codesGerm cell tumour of any site for Neoadjuvant, adjuvant or metastatic first line
  MO004Dhttp://hcxprotocol.io/codes/informational-messages-codesGerm cell tumour second line therapy
  MO005Ahttp://hcxprotocol.io/codes/informational-messages-codesFirst line therapy for high - risk Gestational Trophoblastic Neoplasia Second line
  MO005Chttp://hcxprotocol.io/codes/informational-messages-codesFirst line therapy for low risk Gestational Trophoblastic Neoplasia
  MO006Ahttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant and metastatic Cervical Cancer
  MO006Bhttp://hcxprotocol.io/codes/informational-messages-codesStage II and Stage III cervical cancer definitive therapy along with Radiation therapy
  MO007Ahttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, Adjuvant and Metastatic Endometrial Cancer
  MO007Bhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic Endometrial Cancer
  MO008Ahttp://hcxprotocol.io/codes/informational-messages-codesNACT, mets
  MO008Bhttp://hcxprotocol.io/codes/informational-messages-codesStage II and Stage III cervical cancer definitive therapy
  MO009Ahttp://hcxprotocol.io/codes/informational-messages-codesEwing Sarcoma second line chemotherapy
  MO010Ahttp://hcxprotocol.io/codes/informational-messages-codesOsteogenic carcinoma Neoadjuvant and adjuvant therapy
  MO010Bhttp://hcxprotocol.io/codes/informational-messages-codesRelapsed Osteogenic Sarcoma
  MO010Chttp://hcxprotocol.io/codes/informational-messages-codesOsteogenic carcinoma Neoadjuvant therapy
  MO010Dhttp://hcxprotocol.io/codes/informational-messages-codesOsteogenic carcinoma adjuvant therapy
  MO011Ahttp://hcxprotocol.io/codes/informational-messages-codesNACT, Adjuvant, mets (if cardiac dysfunction)
  MO011Bhttp://hcxprotocol.io/codes/informational-messages-codesSoft tissue sarcoma neoadjuvant, adjuvant and metastatic
  MO012Ahttp://hcxprotocol.io/codes/informational-messages-codesMetastatic Melanoma
  MO013Ahttp://hcxprotocol.io/codes/informational-messages-codesStage II and III anal Cancer
  MO013Chttp://hcxprotocol.io/codes/informational-messages-codesMetastatic Anal Cancer
  MO014Ahttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant and Metastatic Colorectal Cancer
  MO014Bhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic Colorectal Cancer
  MO014Hhttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant and adjuvant Colorectal Cancer
  MO015Ahttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant and adjuvant esophageal cancer
  MO015Bhttp://hcxprotocol.io/codes/informational-messages-codesUpper esophageal neoadjuvant and with RT as adjuvant
  MO015Dhttp://hcxprotocol.io/codes/informational-messages-codesWith RT in definitive non-metastatic
  MO015Ehttp://hcxprotocol.io/codes/informational-messages-codesMetastatic without RT
  MO016Bhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic second line esophageal and stomach cancer
  MO016Chttp://hcxprotocol.io/codes/informational-messages-codesTill RT ends Lower esophageal and stomach Cancer with RT as adjuvant
  MO016Dhttp://hcxprotocol.io/codes/informational-messages-codesTill completion of RT Lower esophageal and stomach Cancer with RT as adjuvant
  MO016Ehttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant and Metastatic Stomach, Lower esophageal (adenocarcinoma) cancer
  MO016Fhttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, adjuvant and metastatic stomach and lower esophageal (adenocarcinoma) cancer
  MO016Jhttp://hcxprotocol.io/codes/informational-messages-codesMetatstaic lower esophageal and stomach Cancer
  MO016Khttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant for stomach and lower esophageal (adenocarcinoma) cancer
  MO016Lhttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, adjuvant, along with Radiation (concurrent), metastatic esophageal cancer
  MO017Ahttp://hcxprotocol.io/codes/informational-messages-codesLiver confined hepatocellular carcinoma
  MO017Bhttp://hcxprotocol.io/codes/informational-messages-codesMeatastatic hepatocellular carcinoma (except child Pugh c) Liver confined but not suitable for liver directed therapy
  MO018Bhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic pancreatic cancer - first line
  MO018Chttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant and adjuvant locally advanced pancreatic cancer
  MO018Ehttp://hcxprotocol.io/codes/informational-messages-codesTill RT ends Neoadjuvant and adjuvant locally advanced pancreatic cancer
  MO018Fhttp://hcxprotocol.io/codes/informational-messages-codesPancreatic cancer - adjuvant
  MO019Ahttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant and metastatic gall bladder and cholnagicarcinoma
  MO019Bhttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, adjuvant and metastatic pancreatic cancer
  MO019Chttp://hcxprotocol.io/codes/informational-messages-codesMetastatic gall bladder and cholngiocarcinoma
  MO019Dhttp://hcxprotocol.io/codes/informational-messages-codesTill RT ends Definitive and Adjuvant therapy in gall bladder cancer
  MO019Ehttp://hcxprotocol.io/codes/informational-messages-codesMetatstatic Gall Bladder Cancer
  MO020Ahttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, adjuvant and metastatic GIST
  MO020Bhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic GIST
  MO021Ahttp://hcxprotocol.io/codes/informational-messages-codesAdjuvant therapy
  MO022Ahttp://hcxprotocol.io/codes/informational-messages-codesMetastatic mesothelioma
  MO022Bhttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant,adjuvant and metastatic mesothelioma
  MO023Ahttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant Chemotherapy and metastatic thymic carcinoma
  MO024Ahttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant and metastatic head and neck squamou cell cancer
  MO024Bhttp://hcxprotocol.io/codes/informational-messages-codesDefinitive therapy
  MO024Chttp://hcxprotocol.io/codes/informational-messages-codesMetastatic squamous cell head and neck cancer, nasopharyngeal cancer, salivary gland cancers
  MO024Dhttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, Metastatic squamou cell head and neck cancer, nasopharyngeal cancer, salivary gland cancers
  MO024Ehttp://hcxprotocol.io/codes/informational-messages-codesMetastatic squamou cell head and neck cancer, salivary gland cancers
  MO024Fhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic Head and neck squamous cell carcinoma
  MO024Ghttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, adjuvant and metastatic esthesioneuroblastoma and Neuroendocrine carcinoma
  MO024Lhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic squamous cell head and neck cancer, salivary gland cancers, nasopharyngeal carcinoma
  MO024Mhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic squamous cell head and neck cancer, salivary gland cancers
  MO025Ahttp://hcxprotocol.io/codes/informational-messages-codesMetastatic renal cell carcinoma
  MO026Ahttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, Metastatic urothelial cancer
  MO026Bhttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, Adjuvant, Metastatic urothelial cancer
  MO026Fhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic urothelial cancer
  MO027Ahttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, Adjuvant, Metastatic penile cancer
  MO027Chttp://hcxprotocol.io/codes/informational-messages-codesMetastatic Penile Cancer
  MO028Ahttp://hcxprotocol.io/codes/informational-messages-codesMetastatic prostate cancer
  MO033Ahttp://hcxprotocol.io/codes/informational-messages-codesMultiagent chemotherapy variable in each protocol
  MO047Chttp://hcxprotocol.io/codes/informational-messages-codesOptional Vincristine and Prednsiolone Intrathecal Methotrexate
  MO048Chttp://hcxprotocol.io/codes/informational-messages-codesOptional Vincristine and Prednsiolone, intrathecal Methotrexate
  MO054Ahttp://hcxprotocol.io/codes/informational-messages-codesHistiocytosis Protocol - Induction
  MO054Bhttp://hcxprotocol.io/codes/informational-messages-codesHistiocytosis Protocol - Maintenance
  MO055Ahttp://hcxprotocol.io/codes/informational-messages-codesLow Grade Glioma
  MO056Ahttp://hcxprotocol.io/codes/informational-messages-codesMedulloblastoma
  MO057Ahttp://hcxprotocol.io/codes/informational-messages-codesNeuroblastoma
  MO058Ahttp://hcxprotocol.io/codes/informational-messages-codesRetinoblastoma
  MO059Ahttp://hcxprotocol.io/codes/informational-messages-codesRhabdomyosarcoma
  MO060Ahttp://hcxprotocol.io/codes/informational-messages-codesRelapsed Rhabdomyosarcoma
  MO062Ahttp://hcxprotocol.io/codes/informational-messages-codesPhase II, CNS Therapy Reinduction
  MO066Ahttp://hcxprotocol.io/codes/informational-messages-codesRelapsed Hodgkins Lymphoma
  MO066Bhttp://hcxprotocol.io/codes/informational-messages-codesHodgkins Lymphoma
  MO068Ahttp://hcxprotocol.io/codes/informational-messages-codesNon - Hodgkins Lymphoma
  MO071Ahttp://hcxprotocol.io/codes/informational-messages-codesMetstatic non small cell lung cancer - second line
  MO071Ehttp://hcxprotocol.io/codes/informational-messages-codesMetastatic non small cell lung (adenocarcinoma) cancer
  MO071Fhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic small cell lung cancer - second line
  MO071Ghttp://hcxprotocol.io/codes/informational-messages-codesMetastatic Non Small Cell Lung Cancer - in patients unfit for combination therapy
  MO071Hhttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, concurrent with radiation and metastaic small cell lung cancer
  MO071Khttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant and Metastatic Non Small Cell Lung cancer
  MO071Ohttp://hcxprotocol.io/codes/informational-messages-codesConcurrent chemoradiation in Non Small Cell lung cancer
  MO071Qhttp://hcxprotocol.io/codes/informational-messages-codesNeoadjuvant, Adjuvant and Metastatic Non Small Cell Lung cancer (adnocarcinoma and adenosquamous carcinoma)
  MO071Rhttp://hcxprotocol.io/codes/informational-messages-codesMetastatic non small cell lung cancer (adenocarcinoma) as maintenance after Carboplatin + Pemetrexed and Cisplatin + Pemetrexed 4 -6 cycles

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
Source The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code